Evidence map›Paper›PMID 42236513›Full record

ArticleScientific reports2026

Stored L-PRF membranes: safety, morphology, tensile properties, and cell viability-an in vitro pilot study.

Jize Yu, Ana Castro Sarda, Nicolas Peredo, Merve Kübra Aktan, Bart Van Meerbeek, Marc Quirynen

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jize YuDepartment of Oral Health Sciences, Periodontology and Oral Microbiology, KU Leuven, 3000, Leuven, Belgium. jizeyu95@gmail.com.
Ana Castro SardaDepartment of Oral Health Sciences, Periodontology and Oral Microbiology, KU Leuven, 3000, Leuven, Belgium.
Nicolas PeredoVIB Bioimaging Core - Center for Brain and Disease Research, KU Leuven, 3000, Leuven, Belgium.
Merve Kübra AktanDepartment of Materials Engineering (MTM), Biomaterials and Tissue Engineering Research Group, KU Leuven, 3001, Leuven, Belgium.
Bart Van MeerbeekDepartment of Oral Health Sciences, BIOMAT, KU Leuven, 3000, Leuven, Belgium.
Marc QuirynenDepartment of Oral Health Sciences, Periodontology and Oral Microbiology, KU Leuven, 3000, Leuven, Belgium.

Funding

China Scholarship Council No. 202206170027
6 · The paper itself

Abstract

This in vitro study aimed to verify the qualitative changes of leukocyte- and platelet-rich fibrin (L-PRF) membranes during their storage. L-PRF membranes from 10 volunteers were stored in their exudate (obtained after compression) at 4 °C for 1, 2, and 4 weeks. The following parameters were compared to the fresh L-PRF membranes: bacterial contamination, macroscopic dimensions, diameter of fibrin fibers and fibrin network porosity (SEM), tensile properties (Young's modulus, tensile stress and strain), and leukocyte viability (live/dead staining & 3D analyses). No bacterial contamination was observed during the storage. After 4 weeks of storage, L-PRF membranes shrank 5.1% in area, and their fibrin fibers decreased by 48.4% in diameter. The Young's modulus of membranes and the stress/strain at maximum load remained at similar levels. The viability of leukocytes decreased from 99.0% at baseline, to 69.1 / 28.5 / 24.6% after 1 / 2 / 4 weeks respectively, starting from the surface towards the interior side. L-PRF membranes could be stored for up to 4 weeks without bacterial contamination and with largely preserved tensile properties. However, leukocyte viability declined substantially over time, which may compromise the biological activity of stored membranes and should be carefully considered in potential applications.

Indexed as

FibrinLeukocytesMembranes, ArtificialPlatelet-Rich FibrinBlood PlateletsCell SurvivalHumansPilot ProjectsTensile StrengthFibrinMembranes, ArtificialAutogenous graftsCell- and tissue-based therapyLeukocyte- and platelet-rich fibrinPlatelet concentratesTissue engineering

Identifiers

PMID42236513
PMCPMC13473516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.